Thesis title: The patentability of CRISPR-Cas9-mediated gene editing in human embryos: Time to “edit” the European patent law landscape?
Mihail is currently in the second year of his PhD studies. Beforehand, he specialised in Intellectual Property Law both as part of his LL.M. studies (at the University of Edinburgh) and his undergraduate degree in law (at the Humboldt University of Berlin).
Mihail is a member of the Scottish Research Centre for IP and Technology Law (SCRIPT) and currently part of the editorial team of the SCRIPTed journal. He is also working as a research assistant at an international law firm.
LL.M. in Intellectual Property Law (University of Edinburgh)
First state exam (Erstes Staatsexamen, Humboldt University of Berlin)
Responsibilities & affiliations
Scottish Research Centre for IP and Technology (SCRIPT)
Mihail is interested in all intellectual property matters. Currently, he is researching on issues at the interface of biotechnology and patent law. In particular, how the EU Biotechnology Directive affects the patentability of processes modifying human embryos via CRISPR-Cas9.